Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
Human papillomavirus (HPV)
Lyme disease, Borreliosis
Adults
2017
Clear all
Type of publications
NITAG documentation
(1)
Systematic reviews (SYSVAC)
(13)
Topics
Available to download in languages
Regions
Americas
(2)
South-East Asia
(2)
Western Pacific
(1)
Countries
Diseases
Human papillomavirus (HPV)
(13)
Lyme disease, Borreliosis
(1)
Dengue
(1)
Haemophilus influenzae type B
(1)
Hepatitis B
(2)
Herpes zoster
(1)
Influenza
(8)
Japanese encephalitis
(1)
Meningococcal disease
(1)
Mumps
(1)
Pneumococcal disease
(7)
Vaccine topics
Acceptance
(1)
Administration
(2)
Coverage
(4)
Economic aspects
(3)
Efficacy/effectiveness
(8)
Safety
(3)
Target population
Adults
(14)
Adolescents
(15)
All age groups
(3)
Healthcare workers
(1)
Older adults
(1)
Parents/caregivers
(4)
Publication date
2017
(14)
2023
(12)
2022
(23)
2021
(22)
2020
(18)
2019
(12)
2018
(12)
2016
(17)
2015
(13)
2014
(15)
2013
(4)
2012
(7)
2011
(1)
14 results found
2017
∙
Badawi, A. Shering, M. Rahman, S. Lindsay, L. R.
A systematic review and meta-analysis for the adverse effects, immunogenicity and efficacy of Lyme disease vaccines: Guiding novel vaccine development
2017
∙
Francis, D. B. Cates, J. R. Wagner, K. P. G. Zola, T. Fitter, J. E. Coyne-Beasley, T.
Communication technologies to improve HPV vaccination initiation and completion: A systematic review
2017
∙
Favato, G. Easton, T. Vecchiato, R. Noikokyris, E.
Ecological validity of cost-effectiveness models of universal HPV vaccination: A systematic literature review
2017
∙
Mousavi, T. Moosazadeh, M. Afshari, M. Davoodi, L. Haghshenas, M.
Efficacy of L1 protein vaccines against cervical and vaginal cancer: A systematic review and meta-analysis
2017
∙
Signorelli, C. Odone, A. Ciorba, V. Cella, P. Audisio, R. A. Lombardi, A. Mariani, L. Mennini, F. S. Pecorelli, S. Rezza, G. Zuccotti, G. V. Peracino, A.
Human papillomavirus 9-valent vaccine for cancer prevention: a systematic review of the available evidence
2017
∙
Bird, Y. Obidiya, O. Mahmood, R. Nwankwo, C. Moraros, J.
Human papillomavirus vaccination uptake in canada: A systematic review and meta-analysis
2017
∙
Tejada, R. A. Vargas, K. G. Benites-Zapata, V. Mezones-Holguin, E. Bolanos-Diaz, R. Hernandez, A. V.
Human papillomavirus vaccine efficacy in the prevention of anogenital warts: systematic review and meta-analysis
2017
∙
Setiawan, D. Luttjeboer, J. Pouwels, K. B. Wilschut, J. C. Postma, M. J.
Immunogenicity and safety of human papillomavirus (HPV) vaccination in Asian populations from six countries: A meta-analysis
2017
∙
Bissett, S. L. Godi, A. Jit, M. Beddows, S.
Seropositivity to non-vaccine incorporated genotypes induced by the bivalent and quadrivalent HPV vaccines: A systematic review and meta-analysis
2017
∙
Gervais, F. Dunton, K. Jiang, YiLing Largeron, N.
Systematic review of cost-effectiveness analyses for combinations of prevention strategies against human papillomavirus (HPV) infection: a general trend
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register